Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

10557	Companies
223261	Keywords
152304	Articles
118147	Press releases

Home
Companies
Biophytis

BRIEF

published on 07/01/2024 at 07:05, 1 year 11 months ago

Biophytis Presents Promising Phase 2-3 COVA Study Results on Severe Covid-19 at WCID in Paris

Biophytis COVID-19 Clinical Trials COVA Study Infectious Diseases
PRESS RELEASE

published on 07/01/2024 at 07:00, 1 year 11 months ago

Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris
Biophytis presents positive results from Phase 2-3 COVA study for severe Covid-19 at WCID Paris. Bio101 shows significant efficacy and safety in reducing risk of respiratory failure and death

Biophytis COVID-19 Positive Results Phase 2-3 COVA Study Respiratory Failure
REGULATED PRESS RELEASE

published on 07/01/2024 at 07:00, 1 year 11 months ago

Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris
Biophytis presented positive results of its Phase 2-3 COVA study for severe Covid-19 at WCID in Paris, showing reduction in respiratory failure and death rates

Biophytis COVID-19 Positive Results Phase 2-3 COVA Study
BRIEF

published on 06/25/2024 at 23:05, 1 year 11 months ago

Biophytis Approves All Resolutions at General Meeting

Shareholders Biophytis General Meeting Resolutions
REGULATED PRESS RELEASE

published on 06/25/2024 at 23:00, 1 year 11 months ago

RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024
Biophytis SA announces the approval of all resolutions at the combined general meeting held on June 24, 2024, with significant shareholder participation

Shareholders General Meeting Resolutions Approval Biophytis SA
BRIEF

published on 06/20/2024 at 07:05, 1 year 11 months ago

Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at Up to €108 Million

Biophytis Pharmaceuticals Latin America BIO101 Blanver
PRESS RELEASE

published on 06/20/2024 at 07:00, 1 year 11 months ago

Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 million. Agreement includes upfront and milestones payments, double-digit royalties, and collaboration on manufacturing and clinical development

Biophytis Latin America Exclusive Rights Blanver Pharmaceutical Deal
REGULATED PRESS RELEASE

published on 06/20/2024 at 07:00, 1 year 11 months ago

Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million. Collaboration for commercialization and clinical development announced

Biophytis Latin America BIO101 Exclusive Rights Blanver
BRIEF

published on 06/20/2024 at 01:15, 1 year 11 months ago

Biophytis extends its contract with Atlas to finance its clinical activities

Biophytis Biotechnology Convertible Bonds Funding Atlas
PRESS RELEASE

published on 06/20/2024 at 01:10, 1 year 11 months ago

Biophytis extends its contract with Atlas to secure financing for its business activities
Biophytis extends financing agreement with Atlas, ensures funding for clinical programs OBA in obesity and MYODA in DMD. Details on the contract amendment and risk factors

Biophytis Atlas Financing Agreement Clinical Programs Risk Factors

Accesswire

Published on 06/12/2026 at 00:00, 1 hour 18 minutes ago

Redwood AI Enters LOI to Explore Pathogen Tracking Through AI Genomics at the Border of Rwanda and the Democratic Republic of Congo with Aim of Potentially Tracing Ebola Virus Disease
Published on 06/12/2026 at 00:00, 1 hour 18 minutes ago

UraniumX Closes Oversubscribed Flow-Through Private Placement
Published on 06/11/2026 at 22:55, 2 hours 23 minutes ago

Gamma Resources to Hold Annual General Meeting on August 12, 2026
Published on 06/11/2026 at 22:15, 3 hours 3 minutes ago

BlackBerry to Hold Annual Meeting of Shareholders on June 25, 2026
Published on 06/11/2026 at 22:05, 3 hours 13 minutes ago

First Canadian Graphite to Present at Planet MicroCap

View all ACCESSWIRE

EQS Group

Published on 06/11/2026 at 22:15, 3 hours 3 minutes ago

HHLA Annual General Meeting resolves transfer of class A shares to majority shareholder
Published on 06/11/2026 at 20:27, 4 hours 51 minutes ago

Turkiye Garanti Bankasi A.S.: Garanti BBVA 2025 TSRS-Aligned Sustainability Report
Published on 06/11/2026 at 19:50, 5 hours 28 minutes ago

GSMA Intelligence Finds Operators Could Be the Real Game-Changers of the 2026 World Cup
Published on 06/11/2026 at 19:30, 5 hours 48 minutes ago

EQS-Adhoc: Tirlán Co-operative Society Limited: PROPOSED SECONDARY PLACING & DIRECTED BUYBACK
Published on 06/11/2026 at 18:47, 6 hours 31 minutes ago

Fuller, Smith & Turner PLC: Director / PDMR Shareholding

Les Echos

Published on 06/11/2026 at 20:30, 4 hours 48 minutes ago

Mersen joins the SBF 120 index
Published on 06/11/2026 at 17:45, 7 hours 33 minutes ago

BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026
Published on 06/11/2026 at 08:45, 16 hours 33 minutes ago

Air Liquide and ArianeGroup renew strategic industrial partnership with two major Ariane 6 contracts
Published on 06/11/2026 at 08:30, 16 hours 48 minutes ago

Aéroports de Paris S.A - €600 million new bond issue
Published on 06/10/2026 at 18:29, 1 day 6 hours ago

ICADE – PR – OUTCOME OF THE COMBINED GENERAL MEETING HELD ON JUNE 10 2026

View all LES ECHOS COMFI WIRE